| 17-May-13 08:37AM | ANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or EDGAR Online +5.17% |
| 13-May-13 05:22PM | Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results PR Newswire |
| 09:01AM | ANTHERA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 07:07AM | Q1 2013 ANTHERA PHARMACEUTICALS INC Earnings Release - After Market Close CCBN |
| 07-May-13 04:30PM | Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study PR Newswire |
| 03-May-13 02:00PM | Anthera Announces First Quarter 2013 Financial Report and Conference Call PR Newswire |
| 08-Apr-13 01:31AM | InPlay: Anthera Pharma refinances existing debt with new $20 mln credit facility; secures $18.5 mln committed equity financing facility Briefing.com |
| 05-Apr-13 05:45PM | Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility PR Newswire |
| 10:22AM | ANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material EDGAR Online |
| 02-Apr-13 07:04PM | On The Fly: After Hours Movers theflyonthewall.com |
| 01-Apr-13 07:27PM | On The Fly: After Hours Movers theflyonthewall.com |
| 06:03PM | ANTH's Blisibimod Enters Phase III Zacks |
| 30-Mar-13 01:04PM | ANTHERA PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 28-Mar-13 03:30PM | 4 Healthcare Stock Stories For Weekend Investment Wellness at Wall St. Cheat Sheet |
| 07:03AM | ANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 27-Mar-13 06:55PM | On The Fly: After Hours Movers theflyonthewall.com |
| 04:16PM | InPlay: Anthera Pharma announced it has initiated the CHABLIS-SC1 Phase 3 study of blisibimod, a novel inhibitor of B-Cell Activating Factor (BAFF) for the treatment of lupus Briefing.com |
| 04:15PM | Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod PR Newswire |
| 26-Mar-13 04:15PM | Anthera Pharmaceuticals Reports 2012 Fourth Quarter And Fiscal Year Financial Results PR Newswire |
| 10:17AM | ANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or EDGAR Online |
| 09:34AM | ANTHERA PHARMACEUTICALS INC Files SEC form 10-K, Annual Report EDGAR Online |
| 22-Mar-13 02:36PM | 4 Healthcare Stock Stories for Weekend Wellness at Wall St. Cheat Sheet |
| 08:00AM | Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus PR Newswire |
| 25-Feb-13 06:01AM | ANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Other Events EDGAR Online -6.06% |
| 13-Feb-13 11:47AM | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Anthera Pharmaceuticals, Inc. in Connection with Executive Compensation Business Wire |
| 08:00AM | Faruqi & Faruqi, LLP is Investigating Anthera Pharmaceuticals Incorporated on Behalf of its Shareholders - ANTH PR Newswire |
| 07-Feb-13 05:29PM | Anthera Pharmaceuticals to Present at the 2013 Leerink Global Healthcare Conference PR Newswire |
| 05-Feb-13 02:04PM | ANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 08:30AM | Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil PR Newswire |
| 30-Jan-13 12:21PM | 5 Stocks Insiders Are Scooping Up at TheStreet |
| 10:15AM | Insiders Buy Stocks in National Beverage, and Sell Costco at Minyanville |
| 09:48AM | Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock PR Newswire |
| 09:29AM | Top Insider Trades: NVR FIZZ COST ANTH at TheStreet |
| 28-Jan-13 05:25PM | ANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material EDGAR Online |
| 25-Jan-13 05:32PM | 4 Healthcare Stock Stories for Weekend Wellness at Wall St. Cheat Sheet -11.11% |
| 08:58AM | InPlay: Anthera Pharma prices underwritten public offering of 60,606,061 shares of its common stock at $0.66 per share Briefing.com |
| 08:57AM | Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock PR Newswire |
| 24-Jan-13 04:03PM | InPlay: Anthera Pharma announces proposed public offering of common stock; size of offering not disclosed Briefing.com |
| 04:01PM | Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock PR Newswire |
| 23-Jan-13 02:55PM | The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Anthera Pharmaceuticals, Inc. in Connection with Executive Compensation PR Newswire |
| 11:56AM | Anthera Shifts Its Strategy For Blisibimod at Seeking Alpha |
| 21-Dec-12 04:18PM | ANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or EDGAR Online |
| 29-Nov-12 08:11AM | Anthera Pharmaceuticals Trading Higher On Additional Data; Need For Capital Could Cap Upside at Seeking Alpha |
| 28-Nov-12 08:03AM | InPlay: Anthera Pharma announces additional data; both the pooled blisibimod treatment group and the 200 mg weekly blisibimod treatment group showed a statistically significant treatment reduction in proteinuria. Briefing.com |
| 08:00AM | Anthera Announces Data from the Phase 2b PEARL-SC Study Presented at the 2012 Asian Lupus Summit PR Newswire |
| 27-Nov-12 10:39AM | Anthera Recovering After Long Fall at Seeking Alpha |
| 20-Nov-12 05:00PM | Anthera Pharmaceuticals to Present at the Piper Jaffray Health Care Conference PR Newswire +6.56% |
| 10:17AM | Biotech Stock Mailbag: Aveo, Anthera, Amarin, MAP Pharma at TheStreet |
| 16-Nov-12 02:47PM | Sabby reports 5.1% passive stake in Anthera Pharmaceuticals at theflyonthewall.com |
| 01:04PM | ANTHERA PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 14-Nov-12 11:28AM | Anthera's Lupus Drug Gets Second Chance After Clinical Trial Disaster at Seeking Alpha -7.35% |
| 10:10AM | Equity Brief: Ratings Changes for November 14th: ABX, ACI, ANTH, AOS, AVEO, BAP, BAX, BIG, BRFS Thomson Reuters ONE |
| 13-Nov-12 05:22PM | InPlay: Anthera Pharma announces additional data from Phase 2b PEARL-SC presented at ACR/AHRP 2012 annual scientific meeting Briefing.com |
| 05:17PM | ANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 05:17PM | Anthera Announces Additional Data from the Phase 2b PEARL-SC Presented at the ACR/ARHP 2012 Annual Scientific Meeting PR Newswire |
| 09:16AM | New Stock Coverage: Berry Plastics Looks Fantastic at Minyanville |
| 08:25AM | Biotech Industry Experiencing More FDA New Drug Approvals in 2012 Marketwire |
| 08:20AM | Biotech Industry Experiencing More FDA New Drug Approvals in 2012 Marketwire |
| 12-Nov-12 08:32AM | PropThink: Galena: One of Biotech's Most Vulnerable Names Thomson Reuters ONE |
| 08-Nov-12 04:58PM | ANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and EDGAR Online -8.64% |
| 04:31PM | ANTHERA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 01-Nov-12 01:53PM | 5 Stocks Under $10 Set to Trade Higher In November at TheStreet +7.87% |
| 01:53PM | 5 Stocks Under $10 Set to Trade Higher in November at TheStreet |
| 08:18AM | Anthera Pharmaceuticals announces Phase 2b PEARL-SC poster presentation at theflyonthewall.com |
| 08:00AM | Anthera Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the ACR/ARHP 2012 Annual Scientific Meeting PR Newswire |
| 25-Oct-12 11:16AM | ANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a EDGAR Online |
| 09:46AM | New Star Analyst Rankings for Anthera Pharmaceuticals, Inc. StarMine |
| 24-Oct-12 05:00PM | Anthera Pharmaceuticals Reports 2012 Third Quarter Financial Results And Provides Clinical Progress Update PR Newswire |
| 07:07AM | Q3 2012 ANTHERA PHARMACEUTICALS INC Earnings Release - After Market Close CCBN |
| 18-Oct-12 05:00PM | Anthera Announces Third Quarter 2012 Financial Report and Conference Call PR Newswire |
| 05-Oct-12 01:03PM | Pick Biotech Winners Like A Pro: John McCamant at Seeking Alpha |
| 02-Oct-12 06:03AM | ANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online -5.00% |
| 20-Sep-12 08:20AM | Faster FDA Review Process a Contributing Factor to Biotech Industry's Rise in 2012 Marketwire |
| 19-Sep-12 02:42PM | A Potential 36-Bagger Biotech at Motley Fool -5.88% |
| 17-Sep-12 04:50PM | Anthera prepares for late-stage lupus drug trials AP +12.90% |
| 08:04AM | InPlay: Anthera Pharma announces the advancement of blisibimod into Phase 3 development for patients with systemic lupus erythematosus Briefing.com |
| 08:02AM | Anthera announces advancement of blisibimod in Phase 3 development at theflyonthewall.com |
| 08:00AM | Anthera Announces the Advancement of Blisibimod into Phase 3 Development for Patients with Systemic Lupus Erythematosus (SLE) PR Newswire |
| 28-Aug-12 04:09PM | Was The HGSI Acquisition A Good Move For GlaxoSmithKline? at Seeking Alpha |
| 27-Aug-12 05:20PM | Opus Point Partners reports 5.27% passive stake in Anthera Pharmaceuticals at theflyonthewall.com -6.12% |
| 16-Aug-12 01:04PM | ANTHERA PHARMACEUTICALS INC Financials EDGAR Online Financials |
| 09-Aug-12 09:01AM | ANTHERA PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 08-Aug-12 09:39AM | New Star Analyst Rankings for Anthera Pharmaceuticals, Inc. StarMine -6.06% |
| 07-Aug-12 05:13PM | ANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a EDGAR Online |
| 04:15PM | Anthera Pharmaceuticals Reports 2012 Second Quarter Financial Results And Provides Clinical Progress Update PR Newswire |
| 11:07AM | What's Driving Stocks Tuesday: ECB And Fed Hope And Fumes at Seeking Alpha |
| 07:07AM | Q2 2012 ANTHERA PHARMACEUTICALS INC Earnings Release - After Market Close CCBN |
| 01-Aug-12 02:00PM | Anthera to Report Second Quarter 2012 Financial Results PR Newswire |
| 02:20AM | Hedge Funds Have Been Buying These Stocks Recently at Seeking Alpha |
| 24-Jul-12 04:15PM | Anthera Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock PR Newswire |
| 20-Jul-12 05:30PM | ANTHERA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and EDGAR Online |
| 19-Jul-12 02:20PM | Healthcare Review: Anthera Pharmaceuticals Jumps, pSivida Corp and Verisante Technology Move On News Developments Thomson Reuters ONE -12.78% |
| 09:16AM | InPlay: Anthera Pharmaceuticals announces pricing of public offering of common stock of $1.00 Briefing.com |
| 09:16AM | Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock PR Newswire |
| 08:20AM | Anthera Pharmaceuticals and Peregrine Pharmaceuticals Set for Growth as Biotech Industry Soaring in 2012 Marketwire |
| 18-Jul-12 06:32PM | Nasdaq stocks posting largest volume increases AP -16.87% |
| 04:24PM | Anthera Pharmaceuticals intends to sell common stock, no amount given theflyonthewall.com |
| 04:23PM | InPlay: Anthera Pharma announces proposed public offering of common stock, size not disclosed Briefing.com |
| 04:22PM | Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock PR Newswire |
| 08:40AM | Healthcare Biz Rewind: StemCells DOUBLES Its Value, Anthera POPS at Wall St. Cheat Sheet |
